Table 1.
Growth inhibition of human cancer cells in vitro by doxorubicin and prodoxorubicin
Time, hr | Treatment | IC50, μM
|
||
---|---|---|---|---|
HT29 | LIM1215 | LNCaP | ||
72 | doxorubicin | 3.0 | 0.4 | 0.4 |
prodoxorubicin | >25 | 18 | 18 | |
120 | doxorubicin | 2.5 | 0.4 | 0.2 |
prodoxorubicin | 22 | 10 | 8 |